AdaptHealth (AHCO) EBITDA (2018 - 2026)

AdaptHealth's EBITDA history runs 9 years deep, the most recent figure standing at $107.1 million for Q1 2026.

• In Q1 2026, EBITDA fell 4.7% year-over-year to $107.1 million; the TTM figure through Mar 2026 stood at $447.1 million (down 23.1% YoY), while the FY2025 annual figure was $452.5 million, down 25.44% from the prior year.
• EBITDA was $107.1 million for Q1 2026 at AdaptHealth, up from $19.2 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of $182.7 million in Q4 2024 to a low of -$370.7 million in Q3 2023.
• Historically, EBITDA has averaged $83.5 million across 5 years, with a median of $128.6 million in 2022.
• The sharpest annual moves came in 2023 and 2024: EBITDA slumped 373.91% in 2023, then soared 239.44% in 2024.
• A 5-year view of EBITDA shows it stood at $119.0 million in 2022, then tumbled by 210.06% to -$131.0 million in 2023, then jumped by 239.44% to $182.7 million in 2024, then sank by 89.48% to $19.2 million in 2025, then soared by 457.15% to $107.1 million in 2026.
• The last three EBITDA figures came in at $107.1 million (Q1 2026), $19.2 million (Q4 2025), and $154.3 million (Q3 2025), per Business Quant data.